Number of the records: 1  

QSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction

  1. 1.
    SYSNO ASEP0538137
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleQSAR-derived affinity fingerprints (part 2): modeling performance for potency prediction
    Author(s) Cortes-Ciriano, I. (GB)
    Škuta, Ctibor (UMG-J)
    Bender, A. (GB)
    Svozil, Daniel (UMG-J)
    Number of authors4
    Article number41
    Source TitleJournal of Cheminformatics. - : Chemistry Central - ISSN 1758-2946
    Roč. 12, č. 1 (2020)
    Number of pages17 s.
    Publication formOnline - E
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsqsar ; Affinity fingerprints ; ChEMBL ; Bioactivity modeling ; Cytotoxicity ; Drug sensitivity prediction ; Drug sensitivity
    Subject RIVEB - Genetics ; Molecular Biology
    OBOR OECDComputer sciences, information science, bioinformathics (hardware development to be 2.2, social aspect to be 5.8)
    R&D ProjectsLM2015063 GA MŠk - Ministry of Education, Youth and Sports (MEYS)
    Způsob publikováníOpen access
    Institutional supportUMG-J - RVO:68378050
    UT WOS000549151400001
    DOI10.1186/s13321-020-00444-5
    AnnotationAffinity fingerprints report the activity of small molecules across a set of assays, and thus permit to gather information about the bioactivities of structurally dissimilar compounds, where models based on chemical structure alone are often limited, and model complex biological endpoints, such as human toxicity and in vitro cancer cell line sensitivity. Here, we propose to model in vitro compound activity using computationally predicted bioactivity profiles as compound descriptors. To this aim, we apply and validate a framework for the calculation of QSAR-derived affinity fingerprints (QAFFP) using a set of 1360 QSAR models generated using K-i, K-d, IC50 and EC50 data from ChEMBL database. QAFFP thus represent a method to encode and relate compounds on the basis of their similarity in bioactivity space. To benchmark the predictive power of QAFFP we assembled IC50 data from ChEMBL database for 18 diverse cancer cell lines widely used in preclinical drug discovery, and 25 diverse protein target data sets. This study complements part 1 where the performance of QAFFP in similarity searching, scaffold hopping, and bioactivity classification is evaluated. Despite being inherently noisy, we show that using QAFFP as descriptors leads to errors in prediction on the test set in the similar to 0.65-0.95 pIC(50) units range, which are comparable to the estimated uncertainty of bioactivity data in ChEMBL (0.76-1.00 pIC(50) units). We find that the predictive power of QAFFP is slightly worse than that of Morgan2 fingerprints and 1D and 2D physicochemical descriptors, with an effect size in the 0.02-0.08 pIC(50) units range. Including QSAR models with low predictive power in the generation of QAFFP does not lead to improved predictive power. Given that the QSAR models we used to compute the QAFFP were selected on the basis of data availability alone, we anticipate better modeling results for QAFFP generated using more diverse and biologically meaningful targets. Data sets and Python code are publicly available at.
    WorkplaceInstitute of Molecular Genetics
    ContactGabriela Marešová, maresova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2021
    Electronic addresshttps://jcheminf.biomedcentral.com/articles/10.1186/s13321-020-00444-5
Number of the records: 1